Comparison between concentrations of racemic mefloquine, its separate enantiomers and the carboxylic acid metabolite in whole blood serum and plasma

European Journal of Clinical Pharmacology

Volumn 51, Issue 2, 1996, Pages 171-173

  Hellgren, U ^a   Jastrebova, J ^b   Jerling, M ^a   Krysen B ^b   Bergqvist, Y ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FALUN HOSPITAL   (Sweden)

^c DALARNA UNIVERSITY   (Sweden)

Author keywords

Acid metabolite; Blood concentrations; Carboxylic; Healthy volunteers; Mefloquine; Mefloquine enantiomers; Pharmacokinetics

Indexed keywords

DRUG METABOLITE; MEFLOQUINE;

ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENANTIOMER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEADY STATE;

ADULT; CARBOXYLIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MEFLOQUINE; MIDDLE AGED; PLASMA; STEREOISOMERISM;

EID: 0029806034     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050180     Document Type: Article

References (10)

1. Basco LK, Gillotin C, Gimenez F, Farinotti R, Le Bras J (1992) In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br J Clin Pharmacol 33:517-520
2. Bergqvist Y, Domeij-Nyberg B (1983) Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 272: 137-148
3. Bergqvist Y, Hellgren U, Churchill FC (1988) High performance liquid Chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr 432:253-263
4. Bergqvist Y, Doverskog M, Kabbani J (1994) High performance liquid Chromatographic determination of (SR) and (RS) enantiomers of mefloquine in plasma and capillary blood samples on paper after derivatization with (-)-1-(9-fluorenyl) ethyl chloroformate. J Chromatogr 652:73-81
5. Gimenez F, Pennie RA, Koren G, Crevoisier C, Wainer IW, Farinotti R (1994) Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple dose. J Pharm Sci 824-827
6. Hellgren U, Hugo Angel V, Bergqvist Y, Arvidsson A, Forero-Gomez JS, Rombo L (1990) Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during long term malaria prophylaxis. Trans Roy Soc Trop Med Hyg 84: 46-49
7. Le Bras M, Ribou G, Brachet Liermain B (1989) La méfloquine se concentre-t-elle dans le globule rouge parasité? Presse Medical 18:492
8. Martin C, Gimenez F, Bangchang KN, Karbwang J, Wainer IW, Farinotti R (1994) Whole blood concentrations of mefloquine enantiomers in healthy Thai volunteers. Eur J Clin Pharmacol 47:85-87
9. Mu JY, Israeli ZH, Dayton PG (1975) Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR30,090. Drug Metab Dispos 3:198-210
10. ter Kuile F, Teja-Isavatharm P, Edstein MD, Keeratithakul D, Dolan G, Nosten F, Phaipun L, Webster KH, White N (1992) Comparison of capillary whole blood, venous whole blood and plasma concentrations of mefloquine, halofantrine and desbutyl-halofantrine measured by high-performance liquid chromatography. Am J Trop Med 51:778-784